Busy. Please wait.

show password
Forgot Password?

Don't have an account?  Sign up 

Username is available taken
show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
We do not share your email address with others. It is only used to allow you to reset your password. For details read our Privacy Policy and Terms of Service.

Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.
Don't know
remaining cards
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
restart all cards
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

Path 6

Neoplasia II pg. 1-6 Templeton

Are the majority of cases of cancer familial or sporadic sporadic
what cells are affected in familial and sporadic cancers sporadic (somatic cells) familial (germline)
How do Oncogenes contribute to cancer new or increased biochemical acivity leads to altered cell phenotype
How can a tumor suppressor gene contribute to cancer loss of activity leads directly to altered cell phenotype
How many genes have to be altered to form a cancer 4-10 (estimate)
what are proto-oncogenes normal genomic constituents with required normal functions in develpment and/or homeostasis
how are proto-oncogenes activated change in genetic coding sequence will lead to new or altered biochemical activity
what happens when bcl-2 is translocated to chromosome 18 where there is a transcriptional enhancer of immunoglobulin the bcl-2 gene product inhibits the activation of the apoptosis protease cascade in the mitochondria protecting from the action of regulatory T cells during tumorigenesis
what are two mechanisms of chromosomal translocation in activation of a proto-oncogene place proto-oncogene under new regulatory elements producing wild-type gene or Splices two coding sequences together resulting in disregulation of biochemical activity of one of the subunits
If Ig enhancers are translocated to the myc gene (chrom 8) you will get inappropriate levels of the myc gene as seen in Burkitt's lymphoma. What is the most common chain to be translocated t(8;14) Ig heavy chain
bcr-able translocation is seen in? leukemia
what is the philadelphia chromosome t(9;22) seen in CML and ALL
How can the same translocation t(9;22) be seen with two different cancers the breakpoint between bcr and abl differ in CML and ALL
what does Gleevec do? inhibits bcr-able kinase activity
what is gene amplification copying of normal genes and their promoters many times
Created by: UVAPATH1